drugset / Trial / NCT05697211

ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF)

NCT05697211

Phase 4 Completed 50 enrolled Hannover Medical School Norgine · collab
NaSingle-groupOpen-labelTreatment

Summary

This is an open-label, single arm, multicenter pilot-study to explore the safety, tolerability and efficacy of oral iron supplementation with ferric maltol in treating iron deficiency and anaemia in patients with heart failure.

Timeline

Start
2023-02-21
Primary completion
2025-01-08
Completion
2025-01-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric maltol Small molecule 30 mg Oral